Rank | Gene Set | Z-score |
---|---|---|
1 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.71321754 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.06217885 |
3 | L-phenylalanine catabolic process (GO:0006559) | 5.06217885 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.05732575 |
5 | L-phenylalanine metabolic process (GO:0006558) | 5.05732575 |
6 | cysteine metabolic process (GO:0006534) | 4.96672264 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 4.80045110 |
8 | regulation of cholesterol esterification (GO:0010872) | 4.68428040 |
9 | sulfur amino acid catabolic process (GO:0000098) | 4.65343070 |
10 | glyoxylate metabolic process (GO:0046487) | 4.60945306 |
11 | tryptophan catabolic process (GO:0006569) | 4.59136975 |
12 | indole-containing compound catabolic process (GO:0042436) | 4.59136975 |
13 | indolalkylamine catabolic process (GO:0046218) | 4.59136975 |
14 | alpha-linolenic acid metabolic process (GO:0036109) | 4.58423039 |
15 | negative regulation of cholesterol transport (GO:0032375) | 4.56817703 |
16 | negative regulation of sterol transport (GO:0032372) | 4.56817703 |
17 | intestinal cholesterol absorption (GO:0030299) | 4.55684827 |
18 | high-density lipoprotein particle remodeling (GO:0034375) | 4.55112689 |
19 | urea cycle (GO:0000050) | 4.54964991 |
20 | urea metabolic process (GO:0019627) | 4.54964991 |
21 | phospholipid efflux (GO:0033700) | 4.54840929 |
22 | kynurenine metabolic process (GO:0070189) | 4.44684341 |
23 | regulation of triglyceride catabolic process (GO:0010896) | 4.37308750 |
24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.35297021 |
25 | homocysteine metabolic process (GO:0050667) | 4.34663767 |
26 | reverse cholesterol transport (GO:0043691) | 4.32904311 |
27 | tryptophan metabolic process (GO:0006568) | 4.29725436 |
28 | drug catabolic process (GO:0042737) | 4.29436000 |
29 | lysine catabolic process (GO:0006554) | 4.25896557 |
30 | lysine metabolic process (GO:0006553) | 4.25896557 |
31 | intestinal absorption (GO:0050892) | 4.21212013 |
32 | plasma lipoprotein particle assembly (GO:0034377) | 4.20164389 |
33 | nitrogen cycle metabolic process (GO:0071941) | 4.15720968 |
34 | regulation of cholesterol homeostasis (GO:2000188) | 4.14354683 |
35 | serine family amino acid catabolic process (GO:0009071) | 4.09932175 |
36 | bile acid biosynthetic process (GO:0006699) | 4.08019486 |
37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.07279354 |
38 | plasma lipoprotein particle remodeling (GO:0034369) | 4.04610761 |
39 | protein-lipid complex remodeling (GO:0034368) | 4.04610761 |
40 | macromolecular complex remodeling (GO:0034367) | 4.04610761 |
41 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.03398907 |
42 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.03022856 |
43 | negative regulation of cell killing (GO:0031342) | 4.03022856 |
44 | amino-acid betaine metabolic process (GO:0006577) | 4.01759100 |
45 | serine family amino acid biosynthetic process (GO:0009070) | 3.99623651 |
46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.94616604 |
47 | protein-lipid complex assembly (GO:0065005) | 3.86516689 |
48 | flavonoid metabolic process (GO:0009812) | 3.85647818 |
49 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.85426945 |
50 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.85426945 |
51 | serine family amino acid metabolic process (GO:0009069) | 3.82399842 |
52 | drug transmembrane transport (GO:0006855) | 3.82114713 |
53 | urate metabolic process (GO:0046415) | 3.77219346 |
54 | proline biosynthetic process (GO:0006561) | 3.75527093 |
55 | glycine metabolic process (GO:0006544) | 3.72268763 |
56 | cholesterol efflux (GO:0033344) | 3.71104397 |
57 | cellular modified amino acid catabolic process (GO:0042219) | 3.71006333 |
58 | Golgi transport vesicle coating (GO:0048200) | 3.70864732 |
59 | COPI coating of Golgi vesicle (GO:0048205) | 3.70864732 |
60 | drug transport (GO:0015893) | 3.68431855 |
61 | hepatocyte apoptotic process (GO:0097284) | 3.67699036 |
62 | NADH metabolic process (GO:0006734) | 3.66954671 |
63 | bile acid and bile salt transport (GO:0015721) | 3.66617057 |
64 | ethanol oxidation (GO:0006069) | 3.65121226 |
65 | bile acid metabolic process (GO:0008206) | 3.62534631 |
66 | lipoprotein metabolic process (GO:0042157) | 3.61789049 |
67 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61531824 |
68 | negative regulation of fibrinolysis (GO:0051918) | 3.60742558 |
69 | cellular glucuronidation (GO:0052695) | 3.58654459 |
70 | protein carboxylation (GO:0018214) | 3.58577240 |
71 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.58577240 |
72 | cholesterol homeostasis (GO:0042632) | 3.57222406 |
73 | complement activation, alternative pathway (GO:0006957) | 3.56578964 |
74 | plasma lipoprotein particle clearance (GO:0034381) | 3.55762985 |
75 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.53885194 |
76 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.53885194 |
77 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.53822042 |
78 | sterol homeostasis (GO:0055092) | 3.53093933 |
79 | aromatic amino acid family metabolic process (GO:0009072) | 3.52325122 |
80 | regulation of protein activation cascade (GO:2000257) | 3.50128317 |
81 | GDP-mannose metabolic process (GO:0019673) | 3.48275992 |
82 | regulation of bile acid biosynthetic process (GO:0070857) | 3.45602615 |
83 | alpha-amino acid catabolic process (GO:1901606) | 3.43409261 |
84 | phospholipid homeostasis (GO:0055091) | 3.41587521 |
85 | plasma lipoprotein particle organization (GO:0071827) | 3.38088642 |
86 | exogenous drug catabolic process (GO:0042738) | 3.37196136 |
87 | acylglycerol homeostasis (GO:0055090) | 3.36113846 |
88 | triglyceride homeostasis (GO:0070328) | 3.36113846 |
89 | glutamate metabolic process (GO:0006536) | 3.35019343 |
90 | proline metabolic process (GO:0006560) | 3.33706121 |
91 | low-density lipoprotein particle remodeling (GO:0034374) | 3.30989411 |
92 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.29487951 |
93 | regulation of fibrinolysis (GO:0051917) | 3.29443395 |
94 | regulation of complement activation (GO:0030449) | 3.28636184 |
95 | thymic T cell selection (GO:0045061) | 3.27540513 |
96 | cellular amino acid catabolic process (GO:0009063) | 3.25679130 |
97 | protein-lipid complex subunit organization (GO:0071825) | 3.23846477 |
98 | response to nitrosative stress (GO:0051409) | 3.23311970 |
99 | angiotensin maturation (GO:0002003) | 3.21753624 |
100 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.21577037 |
101 | uronic acid metabolic process (GO:0006063) | 3.21350645 |
102 | glucuronate metabolic process (GO:0019585) | 3.21350645 |
103 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.21027107 |
104 | interferon-gamma secretion (GO:0072643) | 3.20757824 |
105 | valine metabolic process (GO:0006573) | 3.20658603 |
106 | carnitine metabolic process (GO:0009437) | 3.19697371 |
107 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.16802971 |
108 | regulation of gamma-delta T cell activation (GO:0046643) | 3.15099286 |
109 | indolalkylamine metabolic process (GO:0006586) | 3.14539339 |
110 | benzene-containing compound metabolic process (GO:0042537) | 3.14069366 |
111 | positive regulation of lipid catabolic process (GO:0050996) | 3.13412443 |
112 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.12021372 |
113 | 2-oxoglutarate metabolic process (GO:0006103) | 3.09856317 |
114 | drug metabolic process (GO:0017144) | 3.07183329 |
115 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.06638370 |
116 | desmosome organization (GO:0002934) | 3.06376424 |
117 | amyloid precursor protein catabolic process (GO:0042987) | 3.05497832 |
118 | regulation of cholesterol metabolic process (GO:0090181) | 3.05317619 |
119 | ethanol metabolic process (GO:0006067) | 3.05034550 |
120 | arginine metabolic process (GO:0006525) | 3.04971794 |
121 | glucose 6-phosphate metabolic process (GO:0051156) | 3.04544552 |
122 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.02786380 |
123 | amine catabolic process (GO:0009310) | 3.02569898 |
124 | regulation of extracellular matrix disassembly (GO:0010715) | 3.00230693 |
125 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.95398379 |
126 | detection of bacterium (GO:0016045) | 2.88700229 |
127 | epoxygenase P450 pathway (GO:0019373) | 2.88026325 |
128 | regulation of defense response to virus by virus (GO:0050690) | 2.80755407 |
129 | pentose-phosphate shunt (GO:0006098) | 2.79604343 |
130 | leukocyte aggregation (GO:0070486) | 2.79415386 |
131 | regulation of cellular extravasation (GO:0002691) | 2.76080025 |
132 | regulation of interleukin-13 production (GO:0032656) | 2.74203426 |
133 | positive regulation of interleukin-4 production (GO:0032753) | 2.72965947 |
134 | trophectodermal cell differentiation (GO:0001829) | 2.72199129 |
135 | positive thymic T cell selection (GO:0045059) | 2.71849426 |
136 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.71084480 |
137 | T cell selection (GO:0045058) | 2.69999439 |
138 | negative T cell selection (GO:0043383) | 2.68199993 |
139 | negative thymic T cell selection (GO:0045060) | 2.67508547 |
140 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.66407203 |
141 | detection of other organism (GO:0098543) | 2.66100389 |
142 | maternal placenta development (GO:0001893) | 2.64281555 |
143 | regulation of water loss via skin (GO:0033561) | 2.62527654 |
144 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.61288703 |
145 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.59498594 |
146 | multicellular organismal water homeostasis (GO:0050891) | 2.57932391 |
147 | glucose catabolic process (GO:0006007) | 2.56153396 |
148 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.54985067 |
149 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.49014380 |
150 | amyloid precursor protein metabolic process (GO:0042982) | 2.48868920 |
151 | cellular zinc ion homeostasis (GO:0006882) | 2.47294019 |
152 | ear development (GO:0043583) | 2.46287292 |
153 | pentose metabolic process (GO:0019321) | 2.46204844 |
154 | negative regulation of cell size (GO:0045792) | 2.46108565 |
155 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.45631155 |
156 | NADPH regeneration (GO:0006740) | 2.42422472 |
157 | pinocytosis (GO:0006907) | 2.41729802 |
158 | embryonic process involved in female pregnancy (GO:0060136) | 2.40873705 |
159 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.39596068 |
160 | cellular response to interleukin-4 (GO:0071353) | 2.37672339 |
161 | neutrophil activation involved in immune response (GO:0002283) | 2.37449698 |
162 | response to interleukin-15 (GO:0070672) | 2.37012623 |
163 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.36027898 |
164 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.35575338 |
165 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.35502994 |
166 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.35469732 |
167 | fructose metabolic process (GO:0006000) | 2.34836233 |
168 | cellular response to interleukin-15 (GO:0071350) | 2.34464947 |
169 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.33722183 |
170 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.32319188 |
171 | vitamin transmembrane transport (GO:0035461) | 2.31948920 |
172 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.29872044 |
173 | regulation of extracellular matrix organization (GO:1903053) | 2.28972880 |
174 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.27829554 |
175 | modulation by symbiont of host immune response (GO:0052553) | 2.27829554 |
176 | modulation by symbiont of host defense response (GO:0052031) | 2.27829554 |
177 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.27829554 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.65313255 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.32715564 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.01331522 |
4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.06431914 |
5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.04800157 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.63212676 |
7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.16820143 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.07733057 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.66898538 |
10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.57133596 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.52041447 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.36276667 |
13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.30766099 |
14 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.26054610 |
15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.15929312 |
16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.12483456 |
17 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.09874850 |
18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83687059 |
19 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.75194019 |
20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.68567868 |
21 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.68186521 |
22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67535024 |
23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67140297 |
24 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.65822154 |
25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.63814140 |
26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.62709979 |
27 | MYC_22102868_ChIP-Seq_BL_Human | 1.59934112 |
28 | P68_20966046_ChIP-Seq_HELA_Human | 1.59865552 |
29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.57263651 |
30 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.53518810 |
31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53020270 |
32 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.52916777 |
33 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.52146592 |
34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.49871048 |
35 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.46335996 |
36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44482247 |
37 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.43849543 |
38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43474060 |
39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.41929562 |
40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.41209870 |
41 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.40952897 |
42 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.40636055 |
43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40337826 |
44 | MAF_26560356_Chip-Seq_TH1_Human | 1.39339369 |
45 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.38408351 |
46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.37978884 |
47 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37056502 |
48 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.35389392 |
49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.35135751 |
50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.33970704 |
51 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.33325822 |
52 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32096873 |
53 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.31526998 |
54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.31372515 |
55 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30375405 |
56 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26557688 |
57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.25273653 |
58 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.24580285 |
59 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.23889934 |
60 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23010369 |
61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21668562 |
62 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19081682 |
63 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18350685 |
64 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18299465 |
65 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18046415 |
66 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.17654562 |
67 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16904967 |
68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.16780896 |
69 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15851920 |
70 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15043134 |
71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14815030 |
72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14705437 |
73 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14430122 |
74 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13777308 |
75 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13559217 |
76 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12391169 |
77 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12144280 |
78 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11808200 |
79 | MYB_26560356_Chip-Seq_TH1_Human | 1.11042199 |
80 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11024188 |
81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10862350 |
82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10060551 |
83 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09320163 |
84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.08291482 |
85 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07993104 |
86 | MYB_26560356_Chip-Seq_TH2_Human | 1.07687761 |
87 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06553675 |
88 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06334210 |
89 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.05677141 |
90 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.04637661 |
91 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.03958456 |
92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03925711 |
93 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.03727036 |
94 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.03497569 |
95 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02448876 |
96 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01897085 |
97 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01792551 |
98 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01642721 |
99 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.01489406 |
100 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00898825 |
101 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00894975 |
102 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00627016 |
103 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00167515 |
104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.98879127 |
105 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97052201 |
106 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95789871 |
107 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95358847 |
108 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95027804 |
109 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93239806 |
110 | MAF_26560356_Chip-Seq_TH2_Human | 0.91592281 |
111 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90875491 |
112 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90668965 |
113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90177044 |
114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88438154 |
115 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88131660 |
116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87828146 |
117 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87154657 |
118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86585933 |
119 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.86502956 |
120 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.85688891 |
121 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85554554 |
122 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.85314149 |
123 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84770733 |
124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84097555 |
125 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83936813 |
126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83589406 |
127 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83173359 |
128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83138485 |
129 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.82740117 |
130 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.82443603 |
131 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.82390045 |
132 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.82367109 |
133 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.82316521 |
134 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.82086247 |
135 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81470713 |
136 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.80560819 |
137 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.79903628 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 7.20070964 |
2 | MP0002139_abnormal_hepatobiliary_system | 5.94437587 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.37531131 |
4 | MP0005365_abnormal_bile_salt | 4.16991314 |
5 | MP0009840_abnormal_foam_cell | 3.91153188 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.87521315 |
7 | MP0001666_abnormal_nutrient_absorption | 3.09094739 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.03399103 |
9 | MP0003252_abnormal_bile_duct | 3.02451603 |
10 | MP0010329_abnormal_lipoprotein_level | 2.85443064 |
11 | MP0005332_abnormal_amino_acid | 2.47331487 |
12 | MP0004019_abnormal_vitamin_homeostasis | 2.42848638 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.37362637 |
14 | MP0002138_abnormal_hepatobiliary_system | 1.92479497 |
15 | MP0010234_abnormal_vibrissa_follicle | 1.88541878 |
16 | MP0000609_abnormal_liver_physiology | 1.88467688 |
17 | MP0005083_abnormal_biliary_tract | 1.80487038 |
18 | MP0004381_abnormal_hair_follicle | 1.78618457 |
19 | * MP0009643_abnormal_urine_homeostasis | 1.64807425 |
20 | MP0008260_abnormal_autophagy | 1.63482768 |
21 | MP0002098_abnormal_vibrissa_morphology | 1.59420684 |
22 | MP0005319_abnormal_enzyme/_coenzyme | 1.55260914 |
23 | MP0005501_abnormal_skin_physiology | 1.53745727 |
24 | MP0003705_abnormal_hypodermis_morpholog | 1.53735188 |
25 | MP0002254_reproductive_system_inflammat | 1.53649884 |
26 | MP0003878_abnormal_ear_physiology | 1.53462567 |
27 | MP0005377_hearing/vestibular/ear_phenot | 1.53462567 |
28 | MP0002118_abnormal_lipid_homeostasis | 1.50874251 |
29 | MP0003436_decreased_susceptibility_to | 1.48991596 |
30 | MP0003300_gastrointestinal_ulcer | 1.48799272 |
31 | MP0002396_abnormal_hematopoietic_system | 1.43188013 |
32 | MP0003195_calcinosis | 1.41571877 |
33 | MP0004264_abnormal_extraembryonic_tissu | 1.41116017 |
34 | MP0005076_abnormal_cell_differentiation | 1.39440469 |
35 | MP0000678_abnormal_parathyroid_gland | 1.36792231 |
36 | MP0004782_abnormal_surfactant_physiolog | 1.34731533 |
37 | MP0000685_abnormal_immune_system | 1.33454224 |
38 | MP0000465_gastrointestinal_hemorrhage | 1.33425583 |
39 | MP0003186_abnormal_redox_activity | 1.32566463 |
40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32363698 |
41 | MP0010155_abnormal_intestine_physiology | 1.29515438 |
42 | MP0003172_abnormal_lysosome_physiology | 1.29053096 |
43 | MP0001764_abnormal_homeostasis | 1.28495120 |
44 | MP0009785_altered_susceptibility_to | 1.26859726 |
45 | MP0005464_abnormal_platelet_physiology | 1.25891181 |
46 | MP0004947_skin_inflammation | 1.23638850 |
47 | MP0005075_abnormal_melanosome_morpholog | 1.22993698 |
48 | MP0008469_abnormal_protein_level | 1.22861321 |
49 | MP0009764_decreased_sensitivity_to | 1.21597846 |
50 | MP0010352_gastrointestinal_tract_polyps | 1.20954328 |
51 | MP0001835_abnormal_antigen_presentation | 1.20901838 |
52 | MP0004185_abnormal_adipocyte_glucose | 1.20235229 |
53 | MP0001873_stomach_inflammation | 1.19186737 |
54 | MP0009278_abnormal_bone_marrow | 1.15751891 |
55 | MP0005409_darkened_coat_color | 1.14480062 |
56 | MP0000598_abnormal_liver_morphology | 1.13184675 |
57 | MP0005025_abnormal_response_to | 1.13051425 |
58 | MP0000703_abnormal_thymus_morphology | 1.11801229 |
59 | MP0002089_abnormal_postnatal_growth/wei | 1.10401013 |
60 | MP0002136_abnormal_kidney_physiology | 1.10229536 |
61 | MP0001664_abnormal_digestion | 1.09022685 |
62 | MP0003866_abnormal_defecation | 1.07499775 |
63 | MP0001853_heart_inflammation | 1.05968459 |
64 | * MP0001765_abnormal_ion_homeostasis | 1.04200941 |
65 | MP0001845_abnormal_inflammatory_respons | 1.03591959 |
66 | MP0003868_abnormal_feces_composition | 1.03473636 |
67 | MP0000627_abnormal_mammary_gland | 1.03460322 |
68 | MP0006082_CNS_inflammation | 1.02027808 |
69 | MP0005451_abnormal_body_composition | 1.00882076 |
70 | MP0001800_abnormal_humoral_immune | 0.99594249 |
71 | MP0005058_abnormal_lysosome_morphology | 0.99427844 |
72 | MP0003763_abnormal_thymus_physiology | 0.99055936 |
73 | * MP0005636_abnormal_mineral_homeostasis | 0.98943437 |
74 | MP0004858_abnormal_nervous_system | 0.96926587 |
75 | MP0000604_amyloidosis | 0.95203025 |
76 | MP0009763_increased_sensitivity_to | 0.94434725 |
77 | MP0002419_abnormal_innate_immunity | 0.91908678 |
78 | MP0005387_immune_system_phenotype | 0.91851617 |
79 | MP0001790_abnormal_immune_system | 0.91851617 |
80 | MP0001849_ear_inflammation | 0.90929785 |
81 | MP0000462_abnormal_digestive_system | 0.90659123 |
82 | MP0003724_increased_susceptibility_to | 0.89769537 |
83 | MP0003656_abnormal_erythrocyte_physiolo | 0.88662787 |
84 | MP0005671_abnormal_response_to | 0.87270779 |
85 | MP0005084_abnormal_gallbladder_morpholo | 0.85840150 |
86 | * MP0003638_abnormal_response/metabolism_ | 0.85796382 |
87 | MP0002166_altered_tumor_susceptibility | 0.85590088 |
88 | MP0003303_peritoneal_inflammation | 0.85018856 |
89 | MP0002723_abnormal_immune_serum | 0.84780596 |
90 | MP0002452_abnormal_antigen_presenting | 0.84303506 |
91 | MP0005000_abnormal_immune_tolerance | 0.83491746 |
92 | MP0009765_abnormal_xenobiotic_induced | 0.83471674 |
93 | MP0003183_abnormal_peptide_metabolism | 0.83370874 |
94 | MP0002796_impaired_skin_barrier | 0.81903826 |
95 | MP0010678_abnormal_skin_adnexa | 0.81380566 |
96 | MP0005310_abnormal_salivary_gland | 0.81357795 |
97 | * MP0009642_abnormal_blood_homeostasis | 0.81336431 |
98 | MP0001756_abnormal_urination | 0.81290025 |
99 | MP0001216_abnormal_epidermal_layer | 0.81118007 |
100 | MP0009379_abnormal_foot_pigmentation | 0.80819175 |
101 | MP0005166_decreased_susceptibility_to | 0.80572457 |
102 | MP0000566_synostosis | 0.80544966 |
103 | MP0009931_abnormal_skin_appearance | 0.80160145 |
104 | MP0005666_abnormal_adipose_tissue | 0.80048375 |
105 | MP0001819_abnormal_immune_cell | 0.77363945 |
106 | MP0001663_abnormal_digestive_system | 0.77093231 |
107 | MP0002420_abnormal_adaptive_immunity | 0.76476165 |
108 | MP0000490_abnormal_crypts_of | 0.76140770 |
109 | MP0003453_abnormal_keratinocyte_physiol | 0.75585585 |
110 | MP0009333_abnormal_splenocyte_physiolog | 0.75007472 |
111 | MP0000689_abnormal_spleen_morphology | 0.74471589 |
112 | MP0005023_abnormal_wound_healing | 0.72653845 |
113 | MP0002722_abnormal_immune_system | 0.72350696 |
114 | * MP0000477_abnormal_intestine_morphology | 0.71558030 |
115 | MP0000716_abnormal_immune_system | 0.69663486 |
116 | MP0002405_respiratory_system_inflammati | 0.69326896 |
117 | MP0003075_altered_response_to | 0.67187214 |
118 | MP0003011_delayed_dark_adaptation | 0.66894917 |
119 | MP0002398_abnormal_bone_marrow | 0.66586220 |
120 | MP0002148_abnormal_hypersensitivity_rea | 0.66345551 |
121 | MP0002429_abnormal_blood_cell | 0.64105465 |
122 | MP0000858_altered_metastatic_potential | 0.63580108 |
123 | MP0009697_abnormal_copulation | 0.62072815 |
124 | MP0002006_tumorigenesis | 0.61953237 |
125 | MP0002132_abnormal_respiratory_system | 0.61758082 |
126 | MP0009053_abnormal_anal_canal | 0.60172778 |
127 | MP0008873_increased_physiological_sensi | 0.60090739 |
128 | MP0001533_abnormal_skeleton_physiology | 0.58922004 |
129 | MP0005376_homeostasis/metabolism_phenot | 0.58783229 |
130 | MP0005381_digestive/alimentary_phenotyp | 0.58565721 |
131 | MP0004043_abnormal_pH_regulation | 0.57936251 |
132 | MP0001881_abnormal_mammary_gland | 0.57157882 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypobetalipoproteinemia (HP:0003563) | 5.42221748 |
2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.35197127 |
3 | Intrahepatic cholestasis (HP:0001406) | 5.18568144 |
4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.12830025 |
5 | Xanthomatosis (HP:0000991) | 5.08366330 |
6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.95099458 |
7 | Deep venous thrombosis (HP:0002625) | 4.73300091 |
8 | Hyperglycinuria (HP:0003108) | 4.17269872 |
9 | Hyperammonemia (HP:0001987) | 3.92389557 |
10 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.81794200 |
11 | Hypolipoproteinemia (HP:0010981) | 3.81686309 |
12 | Prolonged partial thromboplastin time (HP:0003645) | 3.69947446 |
13 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.68262516 |
14 | Abnormality of glycine metabolism (HP:0010895) | 3.68262516 |
15 | Fat malabsorption (HP:0002630) | 3.59963403 |
16 | Hyperlipoproteinemia (HP:0010980) | 3.59337946 |
17 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.54691708 |
18 | Complement deficiency (HP:0004431) | 3.38776006 |
19 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.37659242 |
20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.36119740 |
21 | Abnormality of nucleobase metabolism (HP:0010932) | 3.14942463 |
22 | Ketosis (HP:0001946) | 3.14935885 |
23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.14625323 |
24 | Joint hemorrhage (HP:0005261) | 3.13186313 |
25 | Hyperglycinemia (HP:0002154) | 3.12024622 |
26 | Epidermoid cyst (HP:0200040) | 3.08995284 |
27 | Hydroxyprolinuria (HP:0003080) | 3.07920436 |
28 | Abnormality of proline metabolism (HP:0010907) | 3.07920436 |
29 | Hypercholesterolemia (HP:0003124) | 3.05989624 |
30 | Malnutrition (HP:0004395) | 3.05789702 |
31 | Abnormality of macrophages (HP:0004311) | 3.04399738 |
32 | Abnormality of purine metabolism (HP:0004352) | 3.03584074 |
33 | Myositis (HP:0100614) | 3.00054517 |
34 | Conjugated hyperbilirubinemia (HP:0002908) | 2.98272193 |
35 | Autoimmune thrombocytopenia (HP:0001973) | 2.97373529 |
36 | Acanthocytosis (HP:0001927) | 2.90992790 |
37 | Hypoalphalipoproteinemia (HP:0003233) | 2.86747127 |
38 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.86653126 |
39 | Hypoglycemic coma (HP:0001325) | 2.84724863 |
40 | Flat acetabular roof (HP:0003180) | 2.82951739 |
41 | Recurrent abscess formation (HP:0002722) | 2.77741524 |
42 | Gout (HP:0001997) | 2.74833577 |
43 | Micronodular cirrhosis (HP:0001413) | 2.72437117 |
44 | J-shaped sella turcica (HP:0002680) | 2.72095517 |
45 | Distal lower limb muscle weakness (HP:0009053) | 2.70347547 |
46 | Thin bony cortex (HP:0002753) | 2.70177459 |
47 | Esophageal varix (HP:0002040) | 2.68784007 |
48 | Abnormality of complement system (HP:0005339) | 2.65537301 |
49 | Growth hormone excess (HP:0000845) | 2.65145439 |
50 | Hyperbilirubinemia (HP:0002904) | 2.64868451 |
51 | Orchitis (HP:0100796) | 2.64766703 |
52 | Increased IgE level (HP:0003212) | 2.64141072 |
53 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.64013721 |
54 | Abnormality of methionine metabolism (HP:0010901) | 2.63251173 |
55 | Systemic lupus erythematosus (HP:0002725) | 2.61407282 |
56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60148068 |
57 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.59947119 |
58 | Myocardial infarction (HP:0001658) | 2.54843048 |
59 | Late onset (HP:0003584) | 2.54637544 |
60 | Spastic diplegia (HP:0001264) | 2.53818791 |
61 | Delayed CNS myelination (HP:0002188) | 2.49514201 |
62 | Vascular calcification (HP:0004934) | 2.45163205 |
63 | Asymmetry of the thorax (HP:0001555) | 2.44397423 |
64 | Widely patent fontanelles and sutures (HP:0004492) | 2.44062506 |
65 | Hypochromic anemia (HP:0001931) | 2.43656439 |
66 | Septate vagina (HP:0001153) | 2.43092551 |
67 | Seborrheic dermatitis (HP:0001051) | 2.42275546 |
68 | Metabolic acidosis (HP:0001942) | 2.41502880 |
69 | Increased cerebral lipofuscin (HP:0011813) | 2.41286405 |
70 | Steatorrhea (HP:0002570) | 2.39594908 |
71 | Gastrointestinal infarctions (HP:0005244) | 2.39042208 |
72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.38212453 |
73 | Obstructive lung disease (HP:0006536) | 2.38212453 |
74 | Gastrointestinal inflammation (HP:0004386) | 2.36645460 |
75 | Ketoacidosis (HP:0001993) | 2.36203475 |
76 | Ileus (HP:0002595) | 2.35525469 |
77 | Purpura (HP:0000979) | 2.34159530 |
78 | Hepatocellular carcinoma (HP:0001402) | 2.30700727 |
79 | Meningitis (HP:0001287) | 2.30459050 |
80 | Recurrent bacterial skin infections (HP:0005406) | 2.29520247 |
81 | Gingival bleeding (HP:0000225) | 2.27912397 |
82 | Proximal tubulopathy (HP:0000114) | 2.26719669 |
83 | Right ventricular cardiomyopathy (HP:0011663) | 2.26166328 |
84 | Autoimmune hemolytic anemia (HP:0001890) | 2.24256460 |
85 | Pustule (HP:0200039) | 2.23050000 |
86 | Dicarboxylic aciduria (HP:0003215) | 2.22068700 |
87 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.22068700 |
88 | Abnormality of the intrinsic pathway (HP:0010989) | 2.21667410 |
89 | Prolonged bleeding time (HP:0003010) | 2.16467552 |
90 | Hyperparathyroidism (HP:0000843) | 2.16216570 |
91 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15615605 |
92 | Mucopolysacchariduria (HP:0008155) | 2.15615605 |
93 | Vacuolated lymphocytes (HP:0001922) | 2.14851985 |
94 | Generalized aminoaciduria (HP:0002909) | 2.14441056 |
95 | Pancreatitis (HP:0001733) | 2.12789012 |
96 | Dysostosis multiplex (HP:0000943) | 2.12595576 |
97 | Alkalosis (HP:0001948) | 2.12265254 |
98 | Petechiae (HP:0000967) | 2.12144353 |
99 | Increased IgM level (HP:0003496) | 2.10783220 |
100 | Sensorimotor neuropathy (HP:0007141) | 2.09151961 |
101 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.08869643 |
102 | Increased mean platelet volume (HP:0011877) | 2.07780429 |
103 | Cardiovascular calcification (HP:0011915) | 2.06582195 |
104 | Abnormal platelet volume (HP:0011876) | 2.06300131 |
105 | Optic neuritis (HP:0100653) | 2.05726576 |
106 | Retrobulbar optic neuritis (HP:0100654) | 2.05726576 |
107 | Poikilocytosis (HP:0004447) | 2.05657252 |
108 | Urticaria (HP:0001025) | 2.05605699 |
109 | Inflammation of the large intestine (HP:0002037) | 2.05557353 |
110 | Polygenic inheritance (HP:0010982) | 2.04990656 |
111 | Stomatitis (HP:0010280) | 2.04840635 |
112 | Granulocytopenia (HP:0001913) | 2.04569732 |
113 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.04545503 |
114 | Recurrent fungal infections (HP:0002841) | 2.04457880 |
115 | Abnormality of serum amino acid levels (HP:0003112) | 2.03448263 |
116 | Pili torti (HP:0003777) | 2.03408781 |
117 | Vasculitis (HP:0002633) | 2.03101800 |
118 | Irritability (HP:0000737) | 2.02842461 |
119 | Chronic diarrhea (HP:0002028) | 2.01881737 |
120 | Abnormal platelet function (HP:0011869) | 2.01756499 |
121 | Impaired platelet aggregation (HP:0003540) | 2.01756499 |
122 | Sparse lateral eyebrow (HP:0005338) | 2.01371450 |
123 | Nausea (HP:0002018) | 2.01047607 |
124 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99614238 |
125 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99614238 |
126 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99614238 |
127 | Cellulitis (HP:0100658) | 1.99576932 |
128 | Encephalitis (HP:0002383) | 1.99422917 |
129 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99335427 |
130 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.99138568 |
131 | Joint swelling (HP:0001386) | 1.98114225 |
132 | Lethargy (HP:0001254) | 1.97749399 |
133 | Amyloidosis (HP:0011034) | 1.96385996 |
134 | Mediastinal lymphadenopathy (HP:0100721) | 1.94563140 |
135 | Amelogenesis imperfecta (HP:0000705) | 1.94071265 |
136 | Abnormality of iron homeostasis (HP:0011031) | 1.93768704 |
137 | Abnormal cartilage morphology (HP:0002763) | 1.93290767 |
138 | Wide cranial sutures (HP:0010537) | 1.92716269 |
139 | Acute hepatic failure (HP:0006554) | 1.92585228 |
140 | Glycosuria (HP:0003076) | 1.91020276 |
141 | Abnormality of urine glucose concentration (HP:0011016) | 1.91020276 |
142 | Eczematoid dermatitis (HP:0000976) | 1.90683437 |
143 | Easy fatigability (HP:0003388) | 1.90141440 |
144 | Thrombophlebitis (HP:0004418) | 1.89339879 |
145 | Menorrhagia (HP:0000132) | 1.89322010 |
146 | Nasal polyposis (HP:0100582) | 1.89210573 |
147 | Increased purine levels (HP:0004368) | 1.89078468 |
148 | Hyperuricemia (HP:0002149) | 1.89078468 |
149 | Epistaxis (HP:0000421) | 1.88309624 |
150 | Villous atrophy (HP:0011473) | 1.86820756 |
151 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.86820756 |
152 | Colitis (HP:0002583) | 1.86713842 |
153 | * Nephrolithiasis (HP:0000787) | 1.86555460 |
154 | Polycythemia (HP:0001901) | 1.86231297 |
155 | Arterial thrombosis (HP:0004420) | 1.83718810 |
156 | Gingivitis (HP:0000230) | 1.82559978 |
157 | Increased serum ferritin (HP:0003281) | 1.82087422 |
158 | Gastrointestinal dysmotility (HP:0002579) | 1.81057150 |
159 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.81050987 |
160 | Testicular neoplasm (HP:0010788) | 1.80241612 |
161 | Combined immunodeficiency (HP:0005387) | 1.79882197 |
162 | Abnormality of T cells (HP:0002843) | 1.79774557 |
163 | Bone pain (HP:0002653) | 1.79531334 |
164 | Hemorrhage of the eye (HP:0011885) | 1.79092687 |
165 | Megaloblastic anemia (HP:0001889) | 1.78878755 |
166 | Confusion (HP:0001289) | 1.78799647 |
167 | Abdominal distention (HP:0003270) | 1.78322743 |
168 | Glomerulonephritis (HP:0000099) | 1.78109118 |
169 | Neonatal onset (HP:0003623) | 1.77468743 |
170 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.77420575 |
171 | Abnormal tarsal ossification (HP:0008369) | 1.76651627 |
172 | Concave nail (HP:0001598) | 1.73009888 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 3.78842212 |
2 | BCKDK | 3.32530800 |
3 | MAP4K1 | 3.06902086 |
4 | FGFR4 | 3.02279261 |
5 | SMG1 | 2.83595296 |
6 | MAP3K10 | 2.69046288 |
7 | MST4 | 2.65908422 |
8 | TRIB3 | 2.58063161 |
9 | STK10 | 2.48472615 |
10 | TAOK3 | 2.40687086 |
11 | TYK2 | 2.27465259 |
12 | PKN2 | 2.19681275 |
13 | SIK1 | 2.19015063 |
14 | TBK1 | 2.09660988 |
15 | PTK6 | 2.02662987 |
16 | RIPK4 | 1.96882445 |
17 | MST1R | 1.83170736 |
18 | LRRK2 | 1.77910537 |
19 | PRPF4B | 1.76641289 |
20 | TESK2 | 1.69531337 |
21 | JAK3 | 1.65315445 |
22 | EPHA2 | 1.64169756 |
23 | EEF2K | 1.61482460 |
24 | ZAP70 | 1.59120226 |
25 | MUSK | 1.52407207 |
26 | FLT3 | 1.50146504 |
27 | KDR | 1.49922307 |
28 | MAP3K14 | 1.49538921 |
29 | EPHB1 | 1.49146713 |
30 | RIPK1 | 1.48505731 |
31 | IKBKE | 1.41698953 |
32 | MAP2K3 | 1.37119932 |
33 | BTK | 1.36778823 |
34 | BLK | 1.36246307 |
35 | IRAK3 | 1.33108696 |
36 | MAPK11 | 1.31349072 |
37 | TNK2 | 1.28835292 |
38 | VRK2 | 1.28723786 |
39 | FRK | 1.26656628 |
40 | TXK | 1.23884389 |
41 | MAP3K11 | 1.23815459 |
42 | MAP2K2 | 1.22839340 |
43 | ITK | 1.22177268 |
44 | NLK | 1.20950354 |
45 | NME2 | 1.20662476 |
46 | PIK3CA | 1.18644017 |
47 | KIT | 1.17745282 |
48 | CSK | 1.14524722 |
49 | PRKG2 | 1.14518595 |
50 | SIK3 | 1.14232299 |
51 | ICK | 1.13019711 |
52 | JAK1 | 1.12042131 |
53 | MAP3K3 | 1.09811021 |
54 | MAP3K8 | 1.09690966 |
55 | SCYL2 | 1.07823924 |
56 | PAK4 | 1.05120414 |
57 | LMTK2 | 1.04386643 |
58 | JAK2 | 0.99247518 |
59 | PDPK1 | 0.96444002 |
60 | TAOK2 | 0.96316259 |
61 | PIM1 | 0.94613393 |
62 | CDK4 | 0.93749338 |
63 | RPS6KA4 | 0.89823785 |
64 | TAOK1 | 0.89007154 |
65 | NEK6 | 0.86431617 |
66 | MAP3K7 | 0.85946509 |
67 | RET | 0.83858846 |
68 | PTK2 | 0.83550322 |
69 | CDK6 | 0.83520262 |
70 | FGFR3 | 0.82764045 |
71 | PDK1 | 0.80730189 |
72 | RPS6KB2 | 0.73672759 |
73 | ERBB4 | 0.72801413 |
74 | CSF1R | 0.72211891 |
75 | MAP2K6 | 0.70509596 |
76 | IKBKB | 0.69015586 |
77 | MATK | 0.68657037 |
78 | PRKD2 | 0.67553256 |
79 | LCK | 0.66909906 |
80 | CHUK | 0.66453965 |
81 | MAPKAPK2 | 0.66404675 |
82 | TGFBR2 | 0.65705308 |
83 | FES | 0.65648945 |
84 | BMX | 0.64772470 |
85 | NEK9 | 0.62725980 |
86 | TEC | 0.62430752 |
87 | NEK2 | 0.61945394 |
88 | TESK1 | 0.61469241 |
89 | RPS6KA2 | 0.59751882 |
90 | HIPK2 | 0.59099371 |
91 | SYK | 0.57541000 |
92 | NME1 | 0.56532772 |
93 | CDK12 | 0.56408678 |
94 | IRAK4 | 0.54440216 |
95 | MAP3K12 | 0.54200026 |
96 | STK4 | 0.52585594 |
97 | MAP3K13 | 0.52458296 |
98 | MAP2K1 | 0.50229443 |
99 | ABL2 | 0.49639289 |
100 | DYRK1B | 0.49393870 |
101 | RPS6KC1 | 0.48447448 |
102 | RPS6KL1 | 0.48447448 |
103 | LYN | 0.48407582 |
104 | HCK | 0.48000135 |
105 | CAMKK1 | 0.47902862 |
106 | MAPK4 | 0.46392294 |
107 | KSR2 | 0.46132981 |
108 | PRKAA2 | 0.45787363 |
109 | IRAK2 | 0.43910713 |
110 | ACVR1B | 0.43712014 |
111 | PRKCQ | 0.42391622 |
112 | MAP3K2 | 0.42193099 |
113 | MARK3 | 0.41734390 |
114 | TLK1 | 0.41196300 |
115 | DAPK1 | 0.40196642 |
116 | ERBB2 | 0.39749286 |
117 | MARK2 | 0.39092854 |
118 | MTOR | 0.37490644 |
119 | TGFBR1 | 0.37000307 |
120 | MAPKAPK3 | 0.35738177 |
121 | ILK | 0.34697371 |
122 | PIM2 | 0.32847749 |
123 | NEK1 | 0.30883325 |
124 | * GRK6 | 0.30566714 |
125 | CDK7 | 0.29516255 |
126 | MAP3K1 | 0.28949045 |
127 | MELK | 0.28730577 |
128 | EIF2AK1 | 0.28124786 |
129 | EGFR | 0.27938842 |
130 | PRKCI | 0.27667795 |
131 | MET | 0.27076018 |
132 | GSK3A | 0.26584851 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.43244985 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.41617716 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.35647091 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.62182515 |
5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.49989126 |
6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.44097670 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42230383 |
8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41846229 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35280317 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.32507636 |
11 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.16260156 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.13202526 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.98168329 |
14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.96474866 |
15 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93728860 |
16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.92525626 |
17 | Peroxisome_Homo sapiens_hsa04146 | 1.85946426 |
18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.83542217 |
19 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.80095153 |
20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.80038321 |
21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.77732286 |
22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76305329 |
23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.66598226 |
24 | Bile secretion_Homo sapiens_hsa04976 | 1.65670868 |
25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.64036010 |
26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63375136 |
27 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.62665001 |
28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61206180 |
29 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.55328128 |
30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54382436 |
31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53893467 |
32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53776886 |
33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51596396 |
34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49514997 |
35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49077254 |
36 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.48753666 |
37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47640635 |
38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46426990 |
39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.45612425 |
40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40819201 |
41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.39397113 |
42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.38722510 |
43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.35313040 |
44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.33245721 |
45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30368726 |
46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.29181446 |
47 | Thyroid cancer_Homo sapiens_hsa05216 | 1.28795990 |
48 | Sulfur relay system_Homo sapiens_hsa04122 | 1.26832900 |
49 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.26284716 |
50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24897252 |
51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.19688941 |
52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.15585439 |
53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.12742728 |
54 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.12104039 |
55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11852251 |
56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.11797444 |
57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06609004 |
58 | ABC transporters_Homo sapiens_hsa02010 | 1.06436436 |
59 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03962598 |
60 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02890775 |
61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00087081 |
62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97839574 |
63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96991259 |
64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95738011 |
65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94221175 |
66 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93934069 |
67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.93145342 |
68 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.91803265 |
69 | Allograft rejection_Homo sapiens_hsa05330 | 0.91717974 |
70 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.91162893 |
71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.89674091 |
72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89419237 |
73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89241154 |
74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86226264 |
75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84504071 |
76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.83828109 |
77 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.80543798 |
78 | Mineral absorption_Homo sapiens_hsa04978 | 0.80531939 |
79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79298152 |
80 | Lysine degradation_Homo sapiens_hsa00310 | 0.79167268 |
81 | Endocytosis_Homo sapiens_hsa04144 | 0.78154522 |
82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77764336 |
83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77650848 |
84 | Lysosome_Homo sapiens_hsa04142 | 0.72428359 |
85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.71318089 |
86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68537518 |
87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68033716 |
88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65374381 |
89 | Hepatitis B_Homo sapiens_hsa05161 | 0.64988958 |
90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63149649 |
91 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.62541089 |
92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62207690 |
93 | Tuberculosis_Homo sapiens_hsa05152 | 0.59675839 |
94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.59417831 |
95 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58427675 |
96 | Shigellosis_Homo sapiens_hsa05131 | 0.56834055 |
97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55712940 |
98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53973017 |
99 | Bladder cancer_Homo sapiens_hsa05219 | 0.53757005 |
100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53753961 |
101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53403733 |
102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52451248 |
103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52021771 |
104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51854023 |
105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51303873 |
106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47511558 |
107 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47437590 |
108 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.46651276 |
109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42284223 |
110 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.39081662 |
111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37404760 |
112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35275192 |
113 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31270979 |
114 | Legionellosis_Homo sapiens_hsa05134 | 0.31100757 |
115 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.30201738 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.30117754 |
117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29150416 |
118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.28478120 |
119 | Other glycan degradation_Homo sapiens_hsa00511 | 0.28403311 |
120 | Hepatitis C_Homo sapiens_hsa05160 | 0.24881588 |
121 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.23050272 |
122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.20867777 |
123 | Measles_Homo sapiens_hsa05162 | 0.18593862 |
124 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.14840434 |
125 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.14550787 |
126 | Influenza A_Homo sapiens_hsa05164 | 0.12740040 |
127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12625376 |
128 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.12025831 |
129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11941889 |
130 | Pertussis_Homo sapiens_hsa05133 | 0.11595570 |
131 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.11361197 |
132 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.10800192 |
133 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.10719219 |
134 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.09426434 |
135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.09359695 |
136 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.08600115 |
137 | Apoptosis_Homo sapiens_hsa04210 | 0.06875238 |